Long COVID risk Less during Omicron compared to Delta Dr. Nandita Mohan23 Jun 2022 9:15 AM ISTA new research published in The Lancet has revealed that The Omicron variant is less likely to cause long COVID than the Delta variant. The findings...
Journal Club - BCG vaccine still effective and protective in newborns Dr. Nandita Mohan7 May 2022 7:38 PM ISTGiven in countries with endemic TB, BCG vaccine has surprisingly been found to protect newborns and young infants against multiple bacterial and viral...
COVID vaccine for children: IAP expert comment Ananya Shrivastava7 May 2022 5:34 PM ISTIndian Academy of Paediatrics, twin cities branch, applauded the decision of the Drug Controller General of India (DCGI) which recently approved a...
Journal Club - Meningitis vaccine to tackle drug resistance in Neisseria gonorrhoeae Isra Zaman7 May 2022 10:00 AM ISTAccording to recently published articles in The Lancet Infectious Diseases journal, the climbing numbers of gonorrhea cases across the globe are an...
Journal Club - Antibiotics in children below 2 years to cause low vaccine response Dr. Nandita Mohan5 May 2022 10:15 AM ISTThe majority of children are given antibiotics in the first 2 years of life when vaccine-induced immunity develops. Previous studies have shown a...
DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children Dr. Nandita Mohan27 April 2022 5:43 PM ISTThe Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for...
Exemption to SII pneumococcal vaccine from price control for 5 years: NPPA Roshni Dhar20 April 2022 2:37 PM ISTIn a major relief to Serum Institute of India, the drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has decided to grant...
Cadila Pharma unveils three-dose rabies vaccine ThRabis Roshni Dhar12 April 2022 3:07 PM ISTPharmaceutical major Cadila Pharmaceuticals on Friday announced that it has developed the world's first novel three-dose vaccine against rabies.The...
BioNTech to expand clinical trial programme for more anti-Omicron vaccine options MD Bureau31 March 2022 4:53 PM ISTBioNTech said on Wednesday it would expand an ongoing clinical trial programme to develop new vaccines and patterns of administration for better...
Corbevax gets DCGI emergency use nod for 12-18 age group Roshni Dhar23 Feb 2022 4:12 PM ISTBiological E. Limited has announced that its CORBEVAX vaccine, which is India's first indigenously developed Receptor Binding Domain (RBD) Protein...
